Furthermore, research indicates that the presence of mutant PIK3CA circulating tumor DNA (ctDNA) before surgery is associated with poorer outcomes, including shorter relapse-free survival and overall survival, regardless of the specific breast cancer subtype. The gene discussed is PIK3CA; the disease is neoplasm.